Brevan Howard Capital Management’s Agilon Health AGL Stock Holding History

Brevan Howard Capital Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,714	Closed	-$69.9K	–	1731
2025 Q3	$69.9K	Sell	2,714 -10,301	-79%	-$389K	﹤0.01%	1886
2025 Q2	$748K	Buy	13,015 +3,496	+37%	+$280K	﹤0.01%	1200
2025 Q1	$1.03M	Buy	+9,519	New	+$828K	0.01%	488
2024 Q4	–	Sell	-1,098	Closed	-$108K	–	1010
2024 Q3	$108K	Buy	+1,098	New	+$142K	﹤0.01%	1068

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Brevan Howard Capital Management's AGL Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 2,714 shares — an estimated $69.9K sold.

Brevan Howard Capital Management first reported a position in AGL in Q3 2024 and held it in 4 quarters. The position peaked at $1.03M in Q1 2025. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

Brevan Howard Capital Management reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
Brevan Howard Capital Management sold 2,714 Agilon Health shares in Q4 2025, an estimated $69.9K.
Brevan Howard Capital Management first reported a position in Agilon Health in Q3 2024 and held it in 4 quarters.
Brevan Howard Capital Management's Agilon Health position peaked at $1.03M in Q1 2025.
194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.